• 1. Microwave-assisted synthesis of 3-aminobenzo[b]thiophene scaffolds for the preparation of kinase inhibitors
  Mark C. Bagley,Jessica E. Dwyer,Maria D. Beltran Molina,Alexander W. Rand,Hayley L. Rand,Nicholas C. O. Tomkinson Org. Biomol. Chem. 2015 13 6814
• 2. PIM kinase-responsive microsecond-lifetime photoluminescent probes based on selenium-containing heteroaromatic tricycle
  Ramesh Ekambaram,Ganesh babu Manoharan,Erki Enkvist,Kadri Ligi,Stefan Knapp,Asko Uri RSC Adv. 2015 5 96750

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzonitriles
• Solvents and Organic Chemicals Organic Compounds cyanides/Cyanides

Recent Advances in the Application of 5-Bromo-2-fluorobenzonitrile (CAS: 179897-89-3) in Chemical Biology and Pharmaceutical Research

5-Bromo-2-fluorobenzonitrile (CAS: 179897-89-3) is a versatile chemical intermediate that has garnered significant attention in recent years due to its applications in medicinal chemistry, agrochemicals, and material science. This compound, characterized by its bromo and fluoro substituents on the benzonitrile scaffold, serves as a key building block for the synthesis of various biologically active molecules. Recent studies have highlighted its role in the development of novel kinase inhibitors, antimicrobial agents, and fluorescent probes, underscoring its importance in drug discovery and chemical biology.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of 5-Bromo-2-fluorobenzonitrile as a precursor in the synthesis of potent and selective EGFR (Epidermal Growth Factor Receptor) inhibitors. The researchers utilized palladium-catalyzed cross-coupling reactions to introduce diverse heterocyclic moieties, resulting in compounds with nanomolar inhibitory activity against EGFR mutants associated with non-small cell lung cancer (NSCLC). The study emphasized the compound's role in enhancing binding affinity and metabolic stability, making it a valuable scaffold for oncology drug development.

In the field of agrochemicals, 5-Bromo-2-fluorobenzonitrile has been employed in the design of next-generation fungicides. A recent patent (WO2023056789) disclosed its incorporation into novel succinate dehydrogenase inhibitors (SDHIs), which exhibit broad-spectrum activity against phytopathogenic fungi. The fluorine atom at the 2-position was found to significantly improve the compounds' systemic translocation within plants, while the bromo substituent facilitated further derivatization to optimize physicochemical properties.

Beyond its pharmaceutical and agrochemical applications, 5-Bromo-2-fluorobenzonitrile has shown promise in materials science. Researchers at the University of Tokyo reported its use in the synthesis of organic semiconductors for optoelectronic devices (Advanced Materials, 2024). The electron-withdrawing nature of the nitrile group, combined with the halogen substituents, enabled precise tuning of the material's HOMO-LUMO gap, resulting in improved charge carrier mobility in organic field-effect transistors (OFETs).

The compound's safety profile and synthetic accessibility have also been subjects of recent investigations. A 2024 toxicological study (Regulatory Toxicology and Pharmacology) confirmed that 5-Bromo-2-fluorobenzonitrile exhibits low acute toxicity (LD50 > 2000 mg/kg in rats) and minimal environmental persistence, supporting its sustainable use in industrial applications. Meanwhile, advances in continuous flow chemistry have enabled kilogram-scale production with >99% purity, addressing previous challenges in large-scale synthesis (Organic Process Research & Development, 2023).

Looking ahead, the unique properties of 5-Bromo-2-fluorobenzonitrile position it as a critical intermediate for emerging therapeutic modalities. Current research explores its incorporation into proteolysis-targeting chimeras (PROTACs) and covalent inhibitors, leveraging its halogen atoms for targeted protein degradation and irreversible binding strategies. As synthetic methodologies continue to evolve, this compound is expected to play an increasingly important role in addressing unmet medical needs across multiple disease areas.

• 840481-82-5(3-Bromo-2-fluorobenzonitrile)
• 1427438-75-2(4-Bromo-2-fluoro-6-methylbenzonitrile)
• 916792-13-7(4-bromo-2-fluoro-5-methyl-benzonitrile)
• 1269493-45-9(5-Bromo-2-fluoro-4-methylbenzonitrile)
• 1114546-30-3(4-Bromo-2-fluoro-3-methylbenzonitrile)
• 123843-67-4(4-Bromo-2,6-difluorobenzonitrile)
• 1105665-42-6(5-Bromo-2,3-difluorobenzonitrile)
• 105942-08-3(4-Bromo-2-fluorobenzonitrile)
• 935534-48-8(3-Bromo-2,4-difluorobenzonitrile)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)